CapsoVision (CV) vs Vivani Medical (VANI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
CapsoVision (CV) has outperformed Vivani Medical (VANI) over the past year, gaining 16.8% versus a loss of 13.6%. CapsoVision is the larger company by market cap ($327.6 million vs $102.8 million), about 3.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CV | VANI |
|---|---|---|
| Share price | $6.11 | $1.14 |
| Market cap | $327.56M | $102.83M |
| 1-day change | -3.17% | +4.59% |
| YTD return | -42.84% | -7.32% |
| 1-year return | +16.83% | -13.64% |
| 5-year return | — | -81.82% |
| EPS (TTM) | $-0.42 | $-0.33 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $13.55M | $0 |
| Revenue growth (YoY) | +15.29% | — |
| Net income (latest FY) | $-25.32M | $-26.61M |
| Gross margin | 52.92% | — |
| Operating margin | -188.25% | — |
| Net margin | -186.77% | — |
| 52-week high | $15.37 | $1.66 |
| 52-week low | $4.50 | $0.80 |
| Distance from 52-week high | -60.25% | -31.37% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +55.48% | +235.96% |
| Average volume | 173.59K | 228.83K |
| Shares outstanding | 53.61M | 90.20M |
| Employees | 99 | 42 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CapsoVision is about 3.2 times larger than Vivani Medical by market value ($327.56M vs $102.83M).
- CV has outperformed VANI by 30.5 percentage points over the past year.
About CapsoVision
CV stock →CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon).
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 99 employees
About Vivani Medical
VANI stock →Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 42 employees
CV vs VANI FAQ
Which is bigger, CapsoVision or Vivani Medical?
CapsoVision (CV) is larger, with a market capitalization of $327.56M compared with $102.83M for Vivani Medical (VANI).
Which stock has performed better over the past year, CV or VANI?
CV returned +16.83% over the past 12 months, compared with -13.64% for VANI (price return, excluding dividends). Past performance does not predict future results.
Are CapsoVision and Vivani Medical in the same industry?
Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.